Berkshire’s Clayton Adds McGuinn, Expands Builder Scale
Clayton Home Building Group, via its Mungo Homes unit, is acquiring McGuinn Homes in Columbia, SC, a move that expand...
Which Performs Better In Retirement Sp 500 Or Multi Asset
This piece evaluates performance in retirement for Sp 500 vs Multi Asset approaches, outlining where each may excel under different conditions.
26,383 articles
Talk About Lousy Timing: Netflix Target Downgrade Insights
Analysts sometimes cut targets right before a big earnings release. This piece explains why that timing can mislead i...
Stock Market Sounds Alarm: Recession Warning From Economist
When the stock market sounds alarm, it signals investors to pause and recheck. This article breaks down why warnings ...
Should Gold While It's Under $5,000 Be Part of Your Plan?
Gold prices surged last year and pulled back from a record. This guide helps you decide if you should gold while it's...
Global Stock Topped Market: Why SPGI Led Today’s Rally
When a heavyweight like SPGI outperforms in a quiet market, it often signals more than a single stock move. This piec...
SpaceX Priced $135: What It Means for Investors
SpaceX hit the public markets with an IPO price of $135 per share, signaling a game-changing moment for growth invest...
We Don’t Want ‘60 to Die: CBS News Keeps Its Beat Alive
Three long-time CBS News correspondents pledged to stay with the program amid a leadership shake-up, signaling a deli...
Tech Leverage Woes: $10,000 FNGU Becomes $8,392 in One Session
A single-session drop in the 3X leveraged FNGU ETN trimmed a $10,000 bet to $8,392, illustrating how tech leverage ca...
Warren Buffett Just Revealed His Berkshire Stock Pick
Warren Buffett’s latest move at Berkshire Hathaway signals a rare, hands-on embrace of a mega-stock. This piece break...
Strategy Price Prediction: MSTR Eyes Breakout After Rally
MicroStrategy stock has jumped 43% in the last month as Bitcoin climbs. A new strategy price prediction: mstr model s...
Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Hexcel This Portfolio After Big Buy: 23% Stake Insight
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status